Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease <i>via</i> the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study

<div>Chemical structure of dehydrovomifoliol analyzed by using the PubChem database. (a) 2D chemical structure of dehydrovomifoliol. (b) 3D chemical structure of dehydrovomifoliol.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease <i>via</i> the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study 

Figure 1 | Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease via the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study 